Contact

Orally Dispersible Tablets (ODT)

API/FDF Drug Development >> Formulation Development >> Buccal / Orodispersible

We offer end to end pharmaceutical formulation development services of ODT tablets ranging from early phase development to clinical supplies for new chemical entities, generics and life cycle extension products.

Contact

Sub-Lingual Tablets

API/FDF Drug Development >> Formulation Development >> Buccal / Orodispersible

We offer end to end pharmaceutical formulation development services of sub lingual tablets ranging from early phase development to clinical supplies for new chemical entities, generics and life cycle extension products.

Contact

Orally Disintegrating Tablets Development

API/FDF Drug Development >> Formulation Development >> Buccal / Orodispersible

Quotient Sciences’ formulation teams have vast experience across an array of drug product formats for administration via oral, inhaled, topical, rectal and parenteral routes.

Contact

Mouth Dissolving Tablet Formulation & Development

API/FDF Drug Development >> Formulation Development >> Buccal / Orodispersible

SUSHEN Medicamentos (SUSHEN), is a global company of end-to-end pharmaceutical services with focus on drug delivery research and product development. SUSHEN’s expertise can bring a complex formulation project in to clinical and bioequivalence with superior quality, innovative solution.

Contact

Sub Lingual Tablet Formulation & Development

API/FDF Drug Development >> Formulation Development >> Buccal / Orodispersible

SUSHEN Medicamentos (SUSHEN), is a global company of end-to-end pharmaceutical services with focus on drug delivery research and product development. SUSHEN’s expertise can bring a complex formulation project in to clinical and bioequivalence with superior quality, innovative solution.

Filter By

Sub Category

Country

India (2)

United Kingdom (1)

Companies